Weiler and Company Inc.

Phase Forward Reports Third Quarter 2009 Results.(Company overview)(Financial report)
Biotech Week; 11/11/2009; 1442 words; ...prior year period. Bob Weiler, chairman and chief executive...and margin expansion." Weiler added, "During the third...quarter, a pharmaceutical company in the top 40 in sales...Highlights Allergan, Inc., a pharmaceutical company...including Covance, INC Research, Parexel, ...

Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council.
Business Wire; 11/6/2009; 1140 words; ...successful technology companies." Accepting the...Chairman and CEO Bob Weiler, himself a recipient...who have made our company the success it is today," said Weiler. "On this occasion...entrepreneurial drive set our company in motion. We are...Leadership Council, Inc. Formed by ...

Provisur Technologies Names Kevin M. Howard Vice President North American Sales, Marketing & Service.
Food Weekly News; 11/5/2009; 1033 words; ...Technologies, Inc., a leading...Provisur's parent company, CC Industries...Beehive[R], Weiler[R], and Young...Technologies, Inc. "We are fortunate...integration of four companies into a single...we believe our company is well positioned...Technologies, Inc. Provisur ...

Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston.(Conference news)
Business Wire; 11/2/2009; 1080 words; ...of Novazyme Pharmaceuticals, Inc. and president and CEO of Amicus...where he ultimately helped the company develop a therapy for Pompe...networking and learning," said Bob Weiler, chairman and CEO, Phase Forward...update on the capabilities of the company's Empirica[TM] Signal and...

Phase Forward Reports Third Quarter 2009 Results.(Financial report)
Business Wire; 10/29/2009; 2402 words; ...prior year period. Bob Weiler, chairman and chief executive...and margin expansion." Weiler added, "During the third...quarter, a pharmaceutical company in the top 40 in sales...Highlights * Allergan, Inc., a pharmaceutical company...including Covance, INC Research, Parexel, ...